Skip to main content

Epistaxis clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for
  • NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial

    Sorry, in progress, not accepting new patients

    The purpose of this research study is to determine whether Doxycycline can be used to control nosebleeds (epistaxis) for patients with Hereditary Hemorrhagic Telangiectasia (HHT). Patients with HHT will be randomized to one of 2 study arms: Doxycycline or Placebo for a period of 2 months followed by a 1-month washout period before switching treatments for a further 2 months period. Observation and evaluation will continue for a period of one month after treatment is completed.

    at UCLA

Our lead scientists for Epistaxis research studies include .